<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00217191</url>
  </required_header>
  <id_info>
    <org_study_id>MRAP040833</org_study_id>
    <secondary_id>PHRC2004:17-06</secondary_id>
    <nct_id>NCT00217191</nct_id>
  </id_info>
  <brief_title>Ibuprofen and Renal Function in Premature Infants</brief_title>
  <official_title>Ibuprofen and Renal Function in Premature Infants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maternite Regionale Universitaire</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ministere de la Sante et de la Protection Sociale, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Maternite Regionale Universitaire</source>
  <brief_summary>
    <textblock>
      Purpose of the study:

        1. To evaluate renal function maturation within the first month of life in very premature
           infants.

        2. To determine whether a treatment with Ibuprofen for patent ductus arteriosus would alter
           renal function maturation at short term and up to 28 days of life.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Ibuprofen has improved the prognosis of infants with Patent Ductus Arteriosus. Several
      studies showed that Ibuprofen has significantly less side effects than Indomethacin that was
      used for this indication. However, experimental studies and few clinical observations
      suggested that side effects on renal function could occur in very premature infants.

      Purpose of the study:

        1. To evaluate renal function maturation within the first month of life in very premature
           infants.

        2. To determine whether a treatment with Ibuprofen for patent ductus arteriosus would alter
           renal function maturation at short term and up to 28 days of life.

      Population:

      At least 120 infants 27 to 31 weeks gestation will be studied. That number will allow to
      demonstrate a 30% difference in creatinine clearance on day 7 postnatally. Careful recording
      of mother and child history, and associated therapies prone to alter renal function should
      allow to improve the use of this treatment.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2004</start_date>
  <completion_date>September 2006</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Creatinine Clearance on day seven postnatally</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of ductus closure after treatment</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of necrotizing enterocolitis</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate and severity of Intraventricular Hemorrhage</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renal function maturation over 28 days</measure>
  </secondary_outcome>
  <enrollment>120</enrollment>
  <condition>Premature Infants</condition>
  <condition>Patent Ductus Arteriosus</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Gestational Age = 27 to 31 weeks

          -  Postnatal age &lt; 48 hours

          -  Parental Consent Obtained

        Exclusion Criteria:

          -  Renal malformation

          -  Urinary tract infection

          -  Renal Failure

          -  Pulmonary Hypertension at echocardiography
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>28 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Michel HASCOET, MD</last_name>
    <role>Study Director</role>
    <affiliation>University of Nancy, France</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AP-HM (NÃ©onatologie)</name>
      <address>
        <city>Marseille</city>
        <zip>13000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maternite Regionale Universitaire</name>
      <address>
        <city>Nancy</city>
        <zip>54042</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://www.maternite.chu-nancy.fr/</url>
    <description>Home page of the hospital</description>
  </link>
  <reference>
    <citation>Gournay V, Roze JC, Kuster A, Daoud P, Cambonie G, Hascoet JM, Chamboux C, Blanc T, Fichtner C, Savagner C, Gouyon JB, Flurin V, Thiriez G. Prophylactic ibuprofen versus placebo in very premature infants: a randomised, double-blind, placebo-controlled trial. Lancet. 2004 Nov 27-Dec 3;364(9449):1939-44.</citation>
    <PMID>15567009</PMID>
  </reference>
  <verification_date>September 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 14, 2005</study_first_submitted>
  <study_first_submitted_qc>September 19, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2005</study_first_posted>
  <last_update_submitted>September 18, 2006</last_update_submitted>
  <last_update_submitted_qc>September 18, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 19, 2006</last_update_posted>
  <keyword>Premature Infants</keyword>
  <keyword>Patent ductus arteriosus</keyword>
  <keyword>Renal function</keyword>
  <keyword>Ibuprofen</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
    <mesh_term>Ductus Arteriosus, Patent</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ibuprofen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

